NAALADase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
A Standard patent application filed on 15 August 1997 credited to Slusher, Barbara S. ; Maclin, Keith M. ; Tays, Kevin L. ; Jackson, Paul F.

Details

Application number :

40677  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

NAALADase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals  

Inventor :

Slusher, Barbara S. ; Maclin, Keith M. ; Tays, Kevin L. ; Jackson, Paul F.  

Agent name :

Cullens Patent and Trade Mark Attorneys  

Address for service :

GPO Box 1074 BRISBANE QLD 4001  

Filing date :

15 August 1997  

Associated companies :

 

Applicant name :

Eisai Inc.  

Applicant address :

100 Tice Boulevard, Woodcliff Lake, New Jersey 07677, United States Of America  

Old name :

Eisai Corporation of North America ; Guilford Pharmaceuticals Inc. ; MGI GP, Inc.  

Original Source :

Go  

Same Inventor

• Methods of cancer treatment using NAALADase inhibitors
• Pharmaceutical compositions and methods of treating compulsive...
• Hydroxy-phosphinyl derivatives useful as naaladase inhibitors
• Certain phosphinyl derivatives useful as naaladase inhibitors
• Inhibitors of naaladase enzyme activity